Have to say, that is a strong post. If all that is true, at this point a long has to hope in some seriously positive result coming up or that some big Pharma type deep pockets will sense real value in the drug.
(To add: I am long with more shares and higher cost-basis than by any means good for my account, but somewhat resigned to whatever be the outcome. My investment was that LL would make it in Covid, especially critical based on eINDs, with other indications being an insurance. Now the insurance has to come through somehow.)